CLINICAL_TRIALS
trial_result
· 2014-06-12
Clinical Trial Update: Efficacy and Safety Study of Fostamatinib Disodium Tablets to Treat T-Cell Lymphoma [Phase 2]
Summary
Phase 2 study evaluating fostamatinib disodium for T-cell lymphoma has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rigel Pharmaceuticals | Conditions: T Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-06-12